"Myasthenia Gravis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disorder of neuromuscular transmission characterized by weakness of cranial and skeletal muscles. Autoantibodies directed against acetylcholine receptors damage the motor endplate portion of the NEUROMUSCULAR JUNCTION, impairing the transmission of impulses to skeletal muscles. Clinical manifestations may include diplopia, ptosis, and weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles. THYMOMA is commonly associated with this condition. (Adams et al., Principles of Neurology, 6th ed, p1459)
| Descriptor ID |
D009157
|
| MeSH Number(s) |
C10.114.656 C10.668.758.725 C20.111.258.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Myasthenia Gravis".
Below are MeSH descriptors whose meaning is more specific than "Myasthenia Gravis".
This graph shows the total number of publications written about "Myasthenia Gravis" by people in this website by year, and whether "Myasthenia Gravis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 1 | 2 |
| 1999 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myasthenia Gravis" by people in Profiles.
-
Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG-CE). Muscle Nerve. 2021 09; 64(3):270-276.
-
Outcomes After Transcervical Thymectomy for Ocular Myasthenia Gravis: A Retrospective Cohort Study With Inverse Probability Weighting. J Neuroophthalmol. 2020 03; 40(1):8-14.
-
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis. Muscle Nerve. 2019 04; 59(4):404-410.
-
Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review. Neurology. 2017 Sep 05; 89(10):1069-1077.
-
Successful electroconvulsive therapy in a patient with myasthenia gravis. J ECT. 2015 Mar; 31(1):e17-8.
-
All that wheezes is not asthma: cognitive bias in pediatric emergency medical decision making. Pediatr Emerg Care. 2014 Feb; 30(2):104-7.
-
Visual and systemic outcomes in pediatric ocular myasthenia gravis. Am J Ophthalmol. 2010 Oct; 150(4):453-459.e3.
-
The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry. 2011 Jun; 82(6):671-3.
-
Immunosuppressive or surgical treatment for ocular Myasthenia Gravis. Arch Neurol. 2007 Dec; 64(12):1792-4.
-
Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25. Am J Ophthalmol. 2006 Dec; 142(6):1026-35.